Drugs that target dynamic microtubules: a new molecular perspective.
Reads0
Chats0
TLDR
The effects of microtubule‐binding chemotherapeutic agents are reviewed from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of micro Tubule assembly or disassembly.Abstract:
Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle apparatus. As such, there is a wide variety of compounds currently in clinical use and in development that act as antimitotic agents by altering microtubule dynamics. Although these diverse molecules are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research. In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of microtubule assembly or disassembly. These “biological vectors” can thus be used as a spatiotemporal context to describe molecular mechanisms by which microtubule-targeting drugs work.read more
Citations
More filters
Journal ArticleDOI
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma.
Sazzad Hassan,Niranjan Awasthi,Jun Li,Fiona Williams,Margaret A. Schwarz,Margaret A. Schwarz,Roderich E. Schwarz,Urs von Holzen +7 more
TL;DR: Nab-paclitaxel as mentioned in this paper is a novel albumin-stabilized, cremophor-free and water soluble nanoparticle formulation of paclitaxels, which has not been tested yet in experimental EAC.
Journal ArticleDOI
BubR1 is frequently repressed in acute myeloid leukemia and its re-expression sensitizes cells to antimitotic therapy
Dominik Schnerch,Andrea Schmidts,Marie Follo,Josefina Udi,Julia Felthaus,Dietmar Pfeifer,Monika Engelhardt,Ralph Wäsch +7 more
TL;DR: It is proposed that the downstream axis of the spindle assembly checkpoint is a promising target for tailored therapies for acute myeloid leukemia as both direct and BubR1-mediated restoration of cyclin B expression enhanced response to spindle poison.
Journal ArticleDOI
Inhibitors of protein–protein interactions: New methodologies to tackle this challenge
TL;DR: Steps towards improving crystallization of protein-protein complexes, identifying the clusters of residues that constitute putative small molecule binding 'hot spots', generating new methods for detecting the binding of small molecules to target proteins, and generating custom libraries via diversity oriented synthesis to enable the identification of natural-product-like hits are taken.
Journal ArticleDOI
Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5.
Samukelisiwe Pretty Khathi,Balakumar Chandrasekaran,Sivanandhan Karunanidhi,Chuin Lean Tham,Frank Kozielski,Nisar Sayyad,Rajshekhar Karpoormath +6 more
TL;DR: These hybrid molecules are unveiled as novel Eg5 inhibitors with promising drug-like properties for future development and the magnitude of the electron-withdrawing functionalities over the hybrids and the critical molecular interactions contributed towards higher in vitro potency of the compounds.
Journal ArticleDOI
The MTH1 inhibitor TH588 is a microtubule-modulating agent that eliminates cancer cells by activating the mitotic surveillance pathway
Nadia Gul,Joakim Karlsson,Carolina Tängemo,Sanna Linsefors,Samuel Tuyizere,Rosie Perkins,Chandu Ala,Zhiyuan Zou,Erik Larsson,Martin O. Bergo,Per Lindahl +10 more
TL;DR: It is concluded that TH588 is a microtubule-modulating agent that activates the mitotic surveillance pathway and thus prevents cancer cells from re-entering the cell cycle.
References
More filters
Journal ArticleDOI
Microtubules as a target for anticancer drugs.
Mary Ann Jordan,Leslie Wilson +1 more
TL;DR: Highly dynamic mitotic-spindle microtubules are among the most successful targets for anticancer therapy, and it is now known that at lower concentrations, microtubule-targeted drugs can suppress micro Tubule dynamics without changingmicrotubule mass; this action leads to mitotic block and apoptosis.
Journal ArticleDOI
Dynamic instability of microtubule growth
TL;DR: It is reported here that microtubules in vitro coexist in growing and shrinking populations which interconvert rather infrequently and this dynamic instability is a general property of micro Tubules and may be fundamental in explaining cellular microtubule organization.
Journal ArticleDOI
Microtubule polymerization dynamics
TL;DR: This review describes progress toward understanding the mechanism of dynamic instability of pure tubulin and discusses the function and regulation of microtubule dynamic instability in living cells.
Journal ArticleDOI
Kinesin and Dynein Superfamily Proteins and the Mechanism of Organelle Transport
TL;DR: This review focuses on the molecular mechanism of organelle transport in cells and describes kinesin and dynein superfamily proteins.
Journal ArticleDOI
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Raimond B. G. Ravelli,Benoît Gigant,Patrick A. Curmi,Isabelle Jourdain,Sylvie Lachkar,André Sobel,Marcel Knossow +6 more
TL;DR: Changes in the subunits of tubulin as it switches from its straight conformation to a curved one correlate with the loss of lateral contacts and provide a rationale for the rapid microtubule depolymerization characteristic of dynamic instability.
Related Papers (5)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet,Mary Ann Jordan +1 more